MAGED4
Melanoma-associated antigen D4
Also known as: KIAA1859, MAGD4_HUMAN, MAGE-E1, MAGE1, MAGED4B, MGC3210
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96JG8
- Gene
- MAGED4
- Ensembl
- ENSG00000154545
- Chromosome
- X
- Canonical length
- 741 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
741 residues, UniProt reviewed canonical sequence.
>Q96JG8|MAGED4
1 MAEGSFSVQS ESYSVEDMDE GSDEVGEEEM VEGNDYEEFG AFGGYGTLTS FDIHILRAFG
61 SLGPGLRILS NEPWELENPV LAQTLVEALQ LDPETLANET AARAANVARA AASNRAARAA
121 AAAARTAFSQ VVASHRVATP QVSGEDTQPT TYAAEAQGPT PEPPLASPQT SQMLVTSKMA
181 APEAPATSAQ SQTGSPAQEA ATEGPSSACA FSQAPCAREV DANRPSTAFL GQNDVFDFTQ
241 PAGVSGMAFP RPKRPAPAQE AATEGPSAAS GVPQTGPGRE VAATRPKTTK SGKALAKTRW
301 VEPQNVVAAA AAKAKMATSI PEPEGAAAAT AQHSAEPWAR MGGKRTKKSK HLDDEYESSE
361 EERETPAVPP TWRASQPSLT VRAQLAPRPP MAPRSQIPSR HVLCLPPRNV TLLQERANKL
421 VKYLMIKDYK KIPIKRADML KDVIREYDEH FPEIIERATY TLEKKFGIHL KEIDKEEHLY
481 ILVCTRDSSA RLLGKTKDTP RLSLLLVILG VIFMNGNRAS EAVLWEALRK MGLRPGVRHP
541 FLGDLRKLIT DDFVKQKYLE YKKIPNSNPP EYEFLWGLRA RHETSKMRVL RFIAQNQNRD
601 PREWKAHFLE AVDDAFKTMD VDMAEEHARA QMRAQMNIGD EALIGRWSWD DIQVELLTWD
661 EDGDFGDAWA RIPFAFWARY HQYILNSNRA NRRATWRAGV SSGTNGGAST SVLDGPSTSS
721 TIRTRNAARA GASFFSWIQH RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAGED4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 17 nTPM
- ovary: 14 nTPM
- choroid plexus: 7.3 nTPM
- endometrium: 6.5 nTPM
- smooth muscle: 5.7 nTPM
- cervix: 5.1 nTPM
Single-cell type
- other brain neurons: 0.4 nCPM
- oligodendrocyte progenitor cells: 0.3 nCPM
- pituitary stem cells: 0.3 nCPM
- brain inhibitory neurons: 0.2 nCPM
- ependymal cells: 0.2 nCPM
- astrocytes: 0.1 nCPM
Immune cell
- naive B-cell: 8.3 nTPM
- T-reg: 5.3 nTPM
- plasmacytoid DC: 3 nTPM
- memory B-cell: 2.7 nTPM
- memory CD4 T-cell: 1.9 nTPM
- total PBMC: 0.9 nTPM
Brain region
- hypothalamus: 131 nTPM
- basal ganglia: 75 nTPM
- medulla oblongata: 65 nTPM
- spinal cord: 62 nTPM
- cerebral cortex: 61 nTPM
- pons: 60 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAGED4.
Disease | ImmuneIEDB
Conditions an epitope on MAGED4 was assayed in.
- oral squamous cell carcinoma T cell
- head and neck squamous cell carcinoma T cell
- melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0.32
- gnomAD missense Z
- 0.84
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAGED4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAGED4 as an antibody target. Whether an autoantibody or antibody against MAGED4 could matter depends on whether native MAGED4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAGED4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAGED4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...